Showing results (11-20 of 238) with videos related to

Sort By:
Pageof 24
Plastic and Reconstructive Surgery|July 29, 2014
Double-blind clinical trial to compare autologous fat grafts versus autologous fat grafts with PDGF: no effect of PDGFJoan Fontdevila, Eva Guisantes, Esteban Martínez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 18, 2003
[Defining AIDS terminology. A practical approach]Jaime Locutura, Benito Almirante, Juan Berenguer, et al.
Acta Oto-Laryngologica|April 10, 2004
Parapharyngeal angiolipoma causing obstructive sleep apnoea syndromeIsam Alobid, Pedro Benítez, Juan Berenguer, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 18, 2018
Early diagnosisSantiago Moreno, Juan Berenguer, María José Fuster-Ruizdeapodaca, et al.
Current HIV/AIDS Reports|June 16, 2010
Hematopoietic stem cell transplantation in patients infected with HIVDavid Serrano, Pilar Miralles, Pascual Balsalobre, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[The infectious disease specialty in Europe and America]Jesús Rodríguez-Baño, Julio Arrizabalaga, Juan Berenguer, et al.
Seminars in Ultrasound, CT, and MR|June 19, 2007
Temporomandibular joint soft-tissue pathology, II: Nondisc abnormalitiesXavier Tomas, Jaume Pomes, Juan Berenguer, et al.
Scientific Reports|August 16, 2018
Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based studyAlejandro Alvaro-Meca, Pablo Ryan, Dariela Micheloud, et al.
European Journal of Internal Medicine|November 6, 2017
Epidemiological trends of deep venous thrombosis in HIV-infected subjects (1997-2013): A nationwide population-based study in SpainAlejandro Alvaro-Meca, Pablo Ryan, Esther Martínez-Larrull, et al.
The Patient|June 6, 2015
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DFAnthony Mills, Will Garner, Anton Pozniak, et al.
Pageof 24